SI2335707T1 - Sestavki sulfoalkil eter ciklodekstrina in metode za njihovo pripravo - Google Patents

Sestavki sulfoalkil eter ciklodekstrina in metode za njihovo pripravo

Info

Publication number
SI2335707T1
SI2335707T1 SI200531989T SI200531989T SI2335707T1 SI 2335707 T1 SI2335707 T1 SI 2335707T1 SI 200531989 T SI200531989 T SI 200531989T SI 200531989 T SI200531989 T SI 200531989T SI 2335707 T1 SI2335707 T1 SI 2335707T1
Authority
SI
Slovenia
Prior art keywords
sae
composition
preparation
methods
sulfoalkyl ether
Prior art date
Application number
SI200531989T
Other languages
English (en)
Inventor
James D. Pipkin
Gerold L. Mosher
Douglas B. Hecker
Original Assignee
Cydex Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37968086&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI2335707(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cydex Pharmaceuticals, Inc. filed Critical Cydex Pharmaceuticals, Inc.
Publication of SI2335707T1 publication Critical patent/SI2335707T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D1/00—Evaporating
    • B01D1/16—Evaporating by spraying
    • B01D1/18—Evaporating by spraying to obtain dry solids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Inorganic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
SI200531989T 2005-10-26 2005-10-26 Sestavki sulfoalkil eter ciklodekstrina in metode za njihovo pripravo SI2335707T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20110161125 EP2335707B1 (en) 2005-10-26 2005-10-26 Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
PCT/US2005/038933 WO2007050075A1 (en) 2005-10-26 2005-10-26 Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof

Publications (1)

Publication Number Publication Date
SI2335707T1 true SI2335707T1 (sl) 2015-09-30

Family

ID=37968086

Family Applications (2)

Application Number Title Priority Date Filing Date
SI200531989T SI2335707T1 (sl) 2005-10-26 2005-10-26 Sestavki sulfoalkil eter ciklodekstrina in metode za njihovo pripravo
SI200532159T SI2952197T1 (sl) 2005-10-26 2005-10-26 Sestavki sulfoalkil eter ciklodekstrina in metode priprave le-tega

Family Applications After (1)

Application Number Title Priority Date Filing Date
SI200532159T SI2952197T1 (sl) 2005-10-26 2005-10-26 Sestavki sulfoalkil eter ciklodekstrina in metode priprave le-tega

Country Status (22)

Country Link
US (1) US8049003B2 (sl)
EP (5) EP2335707B1 (sl)
JP (1) JP5465432B2 (sl)
KR (1) KR101152886B1 (sl)
CN (1) CN101365459B (sl)
AT (1) ATE504305T1 (sl)
AU (1) AU2005337613B2 (sl)
BR (1) BRPI0520654B8 (sl)
CA (2) CA2632211C (sl)
CY (3) CY1116080T1 (sl)
DE (1) DE602005027415D1 (sl)
DK (5) DK1945228T4 (sl)
ES (5) ES2634670T3 (sl)
HK (4) HK1158978A1 (sl)
HU (2) HUE035181T2 (sl)
IL (3) IL191081A (sl)
LT (1) LT2952197T (sl)
MX (1) MX348982B (sl)
PL (4) PL2581078T3 (sl)
PT (5) PT1945228E (sl)
SI (2) SI2335707T1 (sl)
WO (1) WO2007050075A1 (sl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1697035B1 (en) * 2003-12-22 2017-11-15 Warren H. Finlay Powder formation by atmospheric spray-freeze drying
MXPA06012240A (es) 2004-04-23 2007-01-31 Cydex Inc Formulacion para inhalador de polvo seco que contiene eter sulfoalquilico-ciclodextrina.
US7629331B2 (en) 2005-10-26 2009-12-08 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
WO2009018069A2 (en) * 2007-07-30 2009-02-05 Cydex Pharmaceuticals, Inc Mixtures of cyclodextrin derivatives
US8501740B2 (en) * 2007-10-09 2013-08-06 Board Of Regents, The University Of Texas System Methods of treatment of opioid tolerance, physical dependence, pain and addiction with inhibitors of certain growth factor receptors
US7635773B2 (en) 2008-04-28 2009-12-22 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions
US8492538B1 (en) 2009-06-04 2013-07-23 Jose R. Matos Cyclodextrin derivative salts
MX347795B (es) * 2010-08-05 2017-05-12 Siga Tech Inc Formulaciones liquidas de st-246 y metodos.
HUE037660T2 (hu) 2011-01-26 2018-09-28 Allergan Inc Androgén készítmény szembetegség kezelésére
WO2012138529A1 (en) * 2011-04-06 2012-10-11 Dow Global Technologies Llc Novel polysaccharide derivatives and dosage forms
DK2814849T3 (da) 2012-02-15 2020-03-09 Cydex Pharmaceuticals Inc Fremgangsmåde til fremstilling af cyclodextrin-derivater
RU2615385C2 (ru) * 2012-02-28 2017-04-04 Сидекс Фармасьютикалс, Инк. Композиции алкилированного циклодекстрина и способы их получения и применения
WO2014066274A1 (en) 2012-10-22 2014-05-01 Cydex Pharmaceuticals, Inc. Alkylated cyclodextrin compositions and processes for preparing and using the same
CN107970214A (zh) * 2012-11-30 2018-05-01 葛兰素史克公司 新型药物组合物
JP6914188B2 (ja) 2014-08-22 2021-08-04 サイデックス・ファーマシューティカルズ・インコーポレイテッド 分画アルキル化シクロデキストリン組成物ならびにその調製方法および使用方法
CN108348560A (zh) 2015-03-19 2018-07-31 锡德克斯药物公司 包含水飞蓟素和磺烃基醚环糊精的组合物及其使用方法
EP3097962B1 (de) * 2015-05-29 2020-05-13 Symrise AG Vorrichtung zur herstellung von sprühgetrockneten agglomeraten
JP2019530727A (ja) * 2016-10-11 2019-10-24 オクタ ファーマシューティカルズ ラモトリギンを含む経口懸濁液用の粉末
AU2018263924A1 (en) 2017-05-03 2019-11-21 Cydex Pharmaceuticals, Inc. Composition containing cyclodextrin and busulfan
US11007185B2 (en) 2019-08-01 2021-05-18 Incarda Therapeutics, Inc. Antiarrhythmic formulation
AU2021291071A1 (en) 2020-06-18 2023-02-23 Halo Therapeutics Ltd Fatty acid complexes of coronavirus spike protein and their use
EP4243805A1 (en) 2020-08-07 2023-09-20 Gbiotech S.À.R.L. Combination therapies for treating coronavirus infection
WO2022234100A1 (en) 2021-05-06 2022-11-10 Spepharm Ag Pharmaceutical formulations

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3426011A (en) 1967-02-13 1969-02-04 Corn Products Co Cyclodextrins with anionic properties
DE3565475D1 (en) 1984-04-07 1988-11-17 Bayer Ag Process and apparatus for the production of granules
US4920214A (en) 1986-04-16 1990-04-24 American Maize-Products Company Process for producing modified cyclodextrins
US5658894A (en) 1989-04-23 1997-08-19 The Trustees Of The University Of Pennsylvania Compositions for inhibiting restenosis
DK0392608T3 (da) 1989-04-12 1995-11-20 Procter & Gamble Faste konsumentproduktsammensætninger, der indeholder cyclodextrinkomplekser af lille partikelstørrelse
KR0166088B1 (ko) * 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5376645A (en) * 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
US5241059A (en) 1990-05-21 1993-08-31 Toppan Printing Co., Ltd. Cyclodextrin derivatives
US5472954A (en) 1992-07-14 1995-12-05 Cyclops H.F. Cyclodextrin complexation
US5324718A (en) 1992-07-14 1994-06-28 Thorsteinn Loftsson Cyclodextrin/drug complexation
IL111184A (en) 1993-10-08 2000-08-13 Farmarc Nederland B V Of Cito Crystalline inclusion complex of diclofenac with unsubstituted beta-cyclodextrin
FR2735136B1 (fr) 1995-06-08 1997-08-14 Roquette Freres Composition pulverulente d'hydroxypropyl-betacyclodextrine et son procede de preparation.
US5935941A (en) 1997-10-24 1999-08-10 Pitha; Josef Alkylations of cyclodextrins leading to derivatives which have a ridgidly extended cavity
US5874418A (en) * 1997-05-05 1999-02-23 Cydex, Inc. Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use
US6046177A (en) * 1997-05-05 2000-04-04 Cydex, Inc. Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
DE69834154T2 (de) * 1997-07-01 2007-01-25 Pfizer Products Inc., Groton Verfahren zur Herstellung von einem Cyclodextrin
CA2320772A1 (en) 1998-02-23 1999-08-26 Cyclops, Ehf. High-energy cyclodextrin complexes
MA25590A1 (fr) 1998-09-14 2002-12-31 Inhale Therapeutic Syst Agent actif de delivraison de poudre seche
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
TWI242015B (en) 1999-11-29 2005-10-21 Akzo Nobel Nv 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
AUPR272901A0 (en) * 2001-01-25 2001-02-22 Gainful Plan Limited Method of preparing biological materials and preparations produced using same
FR2821844B1 (fr) 2001-03-08 2003-05-23 Roquette Freres Procede de preparation d'une beta-cyclodextrine directement compressible, et beta-cyclodextrine directement compressible ainsi obtenue
US7034013B2 (en) 2001-03-20 2006-04-25 Cydex, Inc. Formulations containing propofol and a sulfoalkyl ether cyclodextrin
US20030028014A1 (en) 2001-04-26 2003-02-06 Chris Sikorski Agglomerated modified cyclodextrin and process for making same
DE10240698A1 (de) 2002-09-04 2004-03-18 Symrise Gmbh & Co. Kg Cyclodextrinpartikel
RU2006118802A (ru) * 2003-10-31 2007-12-10 Дзе Юниверсити Оф Канзас (Us) Сульфоалкилэфирные-алкилэфирные производные циклодекстрина
KR20070007076A (ko) * 2003-12-31 2007-01-12 사이덱스 인크 술포알킬 에테르 γ-시클로덱스트린 및코르티코스테로이드를 함유한 흡입용 제형
MXPA06012240A (es) * 2004-04-23 2007-01-31 Cydex Inc Formulacion para inhalador de polvo seco que contiene eter sulfoalquilico-ciclodextrina.
BRPI0513455A (pt) 2004-07-22 2008-05-06 Pfizer Prod Inc formulação para mascaramento de sabor compreendendo o fármaco em uma forma de dissolução retardada e/ou ciclodextrina em uma forma de dissolução melhorada
US20060128654A1 (en) 2004-12-10 2006-06-15 Chunlin Tang Pharmaceutical formulation of cytidine analogs and derivatives
US20060194762A1 (en) 2004-12-23 2006-08-31 Olaf Reer Composition comprising an epothilone and methods for producing a composition comprising an epothilone
US7629331B2 (en) * 2005-10-26 2009-12-08 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
US7635773B2 (en) * 2008-04-28 2009-12-22 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions

Also Published As

Publication number Publication date
AU2005337613A1 (en) 2007-05-03
HUE025315T2 (en) 2016-02-29
IL244130A0 (en) 2016-04-21
ES2364491T3 (es) 2011-09-05
CN101365459B (zh) 2011-11-30
EP2581078A1 (en) 2013-04-17
BRPI0520654B8 (pt) 2021-05-25
DE602005027415D1 (de) 2011-05-19
DK2583668T3 (en) 2015-01-19
CA2632211C (en) 2016-07-05
HK1184383A1 (en) 2014-01-24
SI2952197T1 (sl) 2017-09-29
LT2952197T (lt) 2017-08-25
HK1218509A1 (zh) 2017-02-24
KR20080063526A (ko) 2008-07-04
CY1119471T1 (el) 2018-03-07
CA2928065A1 (en) 2007-05-03
EP2583668B1 (en) 2014-10-08
ES2542893T3 (es) 2015-08-12
BRPI0520654B1 (pt) 2020-08-11
JP5465432B2 (ja) 2014-04-09
ES2532374T3 (es) 2015-03-26
PL2583668T3 (pl) 2015-05-29
IL269619B (en) 2020-07-30
DK2952197T3 (en) 2017-08-07
IL191081A0 (en) 2009-08-03
KR101152886B1 (ko) 2012-07-09
BRPI0520654A2 (pt) 2009-05-19
CA2632211A1 (en) 2007-05-03
CY1116080T1 (el) 2017-02-08
DK1945228T4 (da) 2015-01-12
EP1945228B2 (en) 2014-11-05
PT1945228E (pt) 2011-07-13
EP2335707B1 (en) 2015-05-06
PL2952197T3 (pl) 2017-09-29
EP2581078B1 (en) 2014-12-10
US20090011037A1 (en) 2009-01-08
EP2952197A1 (en) 2015-12-09
PT2335707E (pt) 2015-09-10
PT2581078E (pt) 2015-03-10
CN101365459A (zh) 2009-02-11
EP1945228B9 (en) 2015-03-11
ES2364491T5 (es) 2015-02-19
PT2952197T (pt) 2017-07-28
AU2005337613B2 (en) 2011-04-28
ES2634670T3 (es) 2017-09-28
JP2009513773A (ja) 2009-04-02
IL244130B (en) 2020-06-30
PT2583668E (pt) 2015-01-05
DK2335707T3 (en) 2015-08-10
ES2526903T3 (es) 2015-01-16
EP2583668A1 (en) 2013-04-24
MX348982B (es) 2017-07-06
EP1945228A1 (en) 2008-07-23
DK1945228T3 (da) 2011-07-25
HK1158978A1 (en) 2012-07-27
CY1116517T1 (el) 2017-03-15
ATE504305T1 (de) 2011-04-15
US8049003B2 (en) 2011-11-01
DK2581078T3 (en) 2015-03-02
EP1945228B1 (en) 2011-04-06
PL2335707T3 (pl) 2015-10-30
HK1184070A1 (en) 2014-01-17
EP2952197B1 (en) 2017-04-26
PL2581078T3 (pl) 2015-07-31
HUE035181T2 (hu) 2018-05-02
WO2007050075A1 (en) 2007-05-03
EP2335707A1 (en) 2011-06-22
IL191081A (en) 2016-03-31
CA2928065C (en) 2019-10-15
EP1945228A4 (en) 2010-04-07
IL269619A (en) 2019-11-28

Similar Documents

Publication Publication Date Title
IL269619B (en) Preparations of sulfoalkyl other than cyclodextrin and methods for their preparation
MX336769B (es) Particulados capaces de fluir.
DE502004008452D1 (de) Mikrogele in nicht-vernetzbaren organischen medien
WO2008131985A3 (de) Biozide zusammensetzung, sowie harzzusammensetzungen, kompositmaterialien und laminate, die diese enthalten
BRPI0909787A2 (pt) composição de moldagem termoplástica, usos da combinação de polieteraminas com óxidos amorfos, e de composições de moldagem trermoplásticas, fibra, folha ou moldagem, e, combinação dos componentes.
ATE446018T1 (de) Süssmittelzusammensetzungen
EP1873167A4 (en) METHOD FOR THE PRODUCTION OF HYDROGELS OF CYCLODEXTRINS WITH GLYCIDYL ETHERS, COMPOSITIONS OBTAINED THEREFOR AND APPLICATIONS THEREOF
IL200847A (en) Oligomer-antihistamine couplings, preparations containing them and their uses
EA200800099A1 (ru) Композиции наночастиц мегестрола
WO2008112277A3 (en) Compositions and methods for treating cancer
WO2007080323A3 (fr) Suspension aqueuse stable de nanotubes de carbone
TW200712129A (en) Silicone material having outstanding viscosity stability
MX2021006926A (es) Composiciones de eter sulfoalquilico-ciclodextrina y metodos de preparacion de las mismas.
WO2006023882A3 (en) Anti-perspirant compositions with improved properties
HK1166610A1 (en) Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
Pfaendner Additives Now and in the Future
SI2581078T1 (sl) Sestavki sulfoalkil etra ciklodekstrina in metode za njihovo pripravo
UA29280U (en) Nanometal aquachelate
TW200609213A (en) Aminocyclohexyl ether compounds and uses thereof
GEP20104890B (en) Polymer concrete
TH68489B (th) องค์ประกอบอัดแบบที่ประกอบรวมด้วยพอลิออกซิเมธิลลีน และซีโอไลท์